| J Clin Invest. 1997 August 1; 100(3): 745–753. doi: 10.1172/JCI119587. | PMCID: PMC508244 |
Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men. E Van Cauter, L Plat, M B Scharf, R Leproult, S Cespedes, M L'Hermite-Balériaux, and G Copinschi Department of Medicine, University of Chicago, Illinois 60637, USA. evacauter@medicine.bsd.uchicago.edu Abstract The aim of this study was to investigate, in normal young men, whether gamma-hydroxybutyrate (GHB), a reliable stimulant of slow-wave (SW) sleep in normal subjects, would simultaneously enhance sleep related growth hormone (GH) secretion. Eight healthy young men participated each in four experiments involving bedtime oral administration of placebo, 2.5, 3.0, and 3.5 g of GHB. Polygraphic sleep recordings were performed every night, and blood samples were obtained at 15-min intervals from 2000 to 0800. GHB effects were mainly observed during the first 2 h after sleep onset. There was a doubling of GH secretion, resulting from an increase of the amplitude and the duration of the first GH pulse after sleep onset. This stimulation of GH secretion was significantly correlated to a simultaneous increase in the amount of sleep stage IV. Abrupt but transient elevations of prolactin and cortisol were also observed, but did not appear to be associated with the concomitant stimulation of SW sleep. Thyrotropin and melatonin profiles were not altered by GHB administration. These data suggest that pharmacological agents that reliably stimulate SW sleep, such as GHB, may represent a novel class of powerful GH secretagogues. Full Text The Full Text of this article is available as a PDF (225K). These references are in PubMed. This may not be the complete list of references from this article. - Van Cauter, E; Plat, L. Physiology of growth hormone secretion during sleep. J Pediatr. 1996 May;128(5 Pt 2):S32–S37. [PubMed]
- Takahashi, Y; Kipnis, DM; Daughaday, WH. Growth hormone secretion during sleep. J Clin Invest. 1968 Sep;47(9):2079–2090. [PubMed]
- Sassin, JF; Parker, DC; Mace, JW; Gotlin, RW; Johnson, LC; Rossman, LG. Human growth hormone release: relation to slow-wave sleep and sleep-walking cycles. Science. 1969 Aug 1;165(892):513–515. [PubMed]
- Holl, RW; Hartman, ML; Veldhuis, JD; Taylor, WM; Thorner, MO. Thirty-second sampling of plasma growth hormone in man: correlation with sleep stages. J Clin Endocrinol Metab. 1991 Apr;72(4):854–861. [PubMed]
- Ocampo-Lim, B; Guo, W; DeMott-Friberg, R; Barkan, AL; Jaffe, CA. Nocturnal growth hormone (GH) secretion is eliminated by infusion of GH-releasing hormone antagonist. J Clin Endocrinol Metab. 1996 Dec;81(12):4396–4399. [PubMed]
- Jarrett, DB; Greenhouse, JB; Miewald, JM; Fedorka, IB; Kupfer, DJ. A reexamination of the relationship between growth hormone secretion and slow wave sleep using delta wave analysis. Biol Psychiatry. 1990 Mar 1;27(5):497–509. [PubMed]
- Born, J; Muth, S; Fehm, HL. The significance of sleep onset and slow wave sleep for nocturnal release of growth hormone (GH) and cortisol. Psychoneuroendocrinology. 1988;13(3):233–243. [PubMed]
- McCracken, JT; Poland, RE; Rubin, RT; Tondo, L. Dose-dependent effects of scopolamine on nocturnal growth hormone secretion in normal adult men: relation to delta-sleep changes. J Clin Endocrinol Metab. 1991 Jan;72(1):90–95. [PubMed]
- Peters, JR; Evans, PJ; Page, MD; Hall, R; Gibbs, JT; Dieguez, C; Scanlon, MF. Cholinergic muscarinic receptor blockade with pirenzepine abolishes slow wave sleep-related growth hormone release in normal adult males. Clin Endocrinol (Oxf). 1986 Aug;25(2):213–217. [PubMed]
- Van Cauter, E; Kerkhofs, M; Caufriez, A; Van Onderbergen, A; Thorner, MO; Copinschi, G. A quantitative estimation of growth hormone secretion in normal man: reproducibility and relation to sleep and time of day. J Clin Endocrinol Metab. 1992 Jun;74(6):1441–1450. [PubMed]
- Copinschi, G; Van Onderbergen, A; L'Hermite-Balériaux, M; Szyper, M; Caufriez, A; Bosson, D; L'Hermite, M; Robyn, C; Turek, FW; Van Cauter, E. Effects of the short-acting benzodiazepine triazolam, taken at bedtime, on circadian and sleep-related hormonal profiles in normal men. Sleep. 1990 Jun;13(3):232–244. [PubMed]
- Copinschi, G; Akseki, E; Moreno-Reyes, R; Leproult, R; L'Hermite-Balériaux, M; Caufriez, A; Vertongen, F; Van Cauter, E. Effects of bedtime administration of zolpidem on circadian and sleep-related hormonal profiles in normal women. Sleep. 1995 Jul;18(6):417–424. [PubMed]
- Mamelak, M; Escriu, JM; Stokan, O. The effects of gamma-hydroxybutyrate on sleep. Biol Psychiatry. 1977 Apr;12(2):273–288. [PubMed]
- Lapierre, O; Montplaisir, J; Lamarre, M; Bedard, MA. The effect of gamma-hydroxybutyrate on nocturnal and diurnal sleep of normal subjects: further considerations on REM sleep-triggering mechanisms. Sleep. 1990 Feb;13(1):24–30. [PubMed]
- Sériès, F; Sériès, I; Cormier, Y. Effects of enhancing slow-wave sleep by gamma-hydroxybutyrate on obstructive sleep apnea. Am Rev Respir Dis. 1992 Jun;145(6):1378–1383. [PubMed]
- Mamelak, M; Scharf, MB; Woods, M. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep. 1986;9(1 Pt 2):285–289. [PubMed]
- Scharf, MB; Brown, D; Woods, M; Brown, L; Hirschowitz, J. The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy. J Clin Psychiatry. 1985 Jun;46(6):222–225. [PubMed]
- Lammers, GJ; Arends, J; Declerck, AC; Ferrari, MD; Schouwink, G; Troost, J. Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study. Sleep. 1993 Apr;16(3):216–220. [PubMed]
- Mamelak, M. Gammahydroxybutyrate: an endogenous regulator of energy metabolism. Neurosci Biobehav Rev. 1989 13(4):187–198.Winter; [PubMed]
- Tunnicliff, G. Significance of gamma-hydroxybutyric acid in the brain. Gen Pharmacol. 1992 Nov;23(6):1027–1034. [PubMed]
- Cash, CD. Gamma-hydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent. Neurosci Biobehav Rev. 1994 18(2):291–304.Summer; [PubMed]
- van Coevorden, A; Mockel, J; Laurent, E; Kerkhofs, M; L'Hermite-Balériaux, M; Decoster, C; Nève, P; Van Cauter, E. Neuroendocrine rhythms and sleep in aging men. Am J Physiol. 1991 Apr;260(4 Pt 1):E651–E661. [PubMed]
- Veldhuis, JD; Liem, AY; South, S; Weltman, A; Weltman, J; Clemmons, DA; Abbott, R; Mulligan, T; Johnson, ML; Pincus, S, et al. Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab. 1995 Nov;80(11):3209–3222. [PubMed]
- Vermeulen, A. Nyctohemeral growth hormone profiles in young and aged men: correlation with somatomedin-C levels. J Clin Endocrinol Metab. 1987 May;64(5):884–888. [PubMed]
- Ho, KY; Evans, WS; Blizzard, RM; Veldhuis, JD; Merriam, GR; Samojlik, E; Furlanetto, R; Rogol, AD; Kaiser, DL; Thorner, MO. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab. 1987 Jan;64(1):51–58. [PubMed]
- Cuneo, RC; Salomon, F; McGauley, GA; Sönksen, PH. The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf). 1992 Nov;37(5):387–397. [PubMed]
- Corpas, E; Harman, SM; Blackman, MR. Human growth hormone and human aging. Endocr Rev. 1993 Feb;14(1):20–39. [PubMed]
- Rosén, T; Hansson, T; Granhed, H; Szucs, J; Bengtsson, BA. Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh). 1993 Sep;129(3):201–206. [PubMed]
- Stanus, E; Lacroix, B; Kerkhofs, M; Mendlewicz, J. Automated sleep scoring: a comparative reliability study of two algorithms. Electroencephalogr Clin Neurophysiol. 1987 Apr;66(4):448–456. [PubMed]
- Stanus, EL; Lacroix, BP; Kerkhofs, M; Mendlewicz, J. Computer-aided sleep staging in clinical environment. Neuropsychobiology. 1988;20(4):178–186. [PubMed]
- Van Cauter, E. Estimating false-positive and false-negative errors in analyses of hormonal pulsatility. Am J Physiol. 1988 Jun;254(6 Pt 1):E786–E794. [PubMed]
- Faria, AC; Veldhuis, JD; Thorner, MO; Vance, ML. Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin. J Clin Endocrinol Metab. 1989 Mar;68(3):535–541. [PubMed]
- Veldhuis, JD; Iranmanesh, A; Johnson, ML; Lizarralde, G. Twenty-four-hour rhythms in plasma concentrations of adenohypophyseal hormones are generated by distinct amplitude and/or frequency modulation of underlying pituitary secretory bursts. J Clin Endocrinol Metab. 1990 Dec;71(6):1616–1623. [PubMed]
- Spiegel, K; Follenius, M; Krieger, J; Sforza, E; Brandenberger, G. Prolactin secretion during sleep in obstructive sleep apnoea patients. J Sleep Res. 1995 Mar;4(1):56–62. [PubMed]
- Bradley, EM; Waterhouse, C. Effect of estrogen administration on extravascular cortisol. J Clin Endocrinol Metab. 1966 Jul;26(7):705–714. [PubMed]
- Van Cauter, E; Shapiro, ET; Tillil, H; Polonsky, KS. Circadian modulation of glucose and insulin responses to meals: relationship to cortisol rhythm. Am J Physiol. 1992 Apr;262(4 Pt 1):E467–E475. [PubMed]
- Yamada, Y; Yamamoto, J; Fujiki, A; Hishikawa, Y; Kaneko, Z. Effect of butyrolactone and gamma-hydroxybutyrate on the EEG and sleep cycle in man. Electroencephalogr Clin Neurophysiol. 1967 Jun;22(6):558–562. [PubMed]
- Gronfier, C; Luthringer, R; Follenius, M; Schaltenbrand, N; Macher, JP; Muzet, A; Brandenberger, G. A quantitative evaluation of the relationships between growth hormone secretion and delta wave electroencephalographic activity during normal sleep and after enrichment in delta waves. Sleep. 1996 Dec;19(10):817–824. [PubMed]
- Krueger, JM; Obál, F., Jr Growth hormone-releasing hormone and interleukin-1 in sleep regulation. FASEB J. 1993 May;7(8):645–652. [PubMed]
- Takahara, J; Yunoki, S; Yakushiji, W; Yamauchi, J; Yamane, Y. Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. J Clin Endocrinol Metab. 1977 May;44(5):1014–1017. [PubMed]
- Scrima, L; Hartman, PG; Johnson, FH, Jr; Thomas, EE; Hiller, FC. The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study. Sleep. 1990 Dec;13(6):479–490. [PubMed]
- Gerra, G; Caccavari, R; Fontanesi, B; Marcato, A; Fertonani Affini, G; Maestri, D; Avanzini, P; Lecchini, R; Delsignore, R; Mutti, A. Flumazenil effects on growth hormone response to gamma-hydroxybutyric acid. Int Clin Psychopharmacol. 1994 Sep;9(3):211–215. [PubMed]
- Gallimberti, L; Cibin, M; Pagnin, P; Sabbion, R; Pani, PP; Pirastu, R; Ferrara, SD; Gessa, GL. Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome. Neuropsychopharmacology. 1993 Aug;9(1):77–81. [PubMed]
- Dyer, JE. gamma-Hydroxybutyrate: a health-food product producing coma and seizurelike activity. Am J Emerg Med. 1991 Jul;9(4):321–324. [PubMed]
- Chin, MY; Kreutzer, RA; Dyer, JE. Acute poisoning from gamma-hydroxybutyrate in California. West J Med. 1992 Apr;156(4):380–384. [PubMed]
- Steele, MT; Watson, WA. Acute poisoning from gamma hydroxybutyrate (GHB). Mo Med. 1995 Jul;92(7):354–357. [PubMed]
- Ross, TM. Gamma hydroxybutyrate overdose: two cases illustrate the unique aspects of this dangerous recreational drug. J Emerg Nurs. 1995 Oct;21(5):374–376. [PubMed]
- Friedman, J; Westlake, R; Furman, M. "Grievous bodily harm:" gamma hydroxybutyrate abuse leading to a Wernicke-Korsakoff syndrome. Neurology. 1996 Feb;46(2):469–471. [PubMed]
- Spiegel, K; Luthringer, R; Follenius, M; Schaltenbrand, N; Macher, JP; Muzet, A; Brandenberger, G. Temporal relationship between prolactin secretion and slow-wave electroencephalic activity during sleep. Sleep. 1995 Sep;18(7):543–548. [PubMed]
- Rudman, D; Feller, AG; Nagraj, HS; Gergans, GA; Lalitha, PY; Goldberg, AF; Schlenker, RA; Cohn, L; Rudman, IW; Mattson, DE. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990 Jul 5;323(1):1–6. [PubMed]
- Rudman, D; Feller, AG; Cohn, L; Shetty, KR; Rudman, IW; Draper, MW. Effects of human growth hormone on body composition in elderly men. Horm Res. 1991;36 Suppl 1:73–81. [PubMed]
- Marcus, R; Butterfield, G; Holloway, L; Gilliland, L; Baylink, DJ; Hintz, RL; Sherman, BM. Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab. 1990 Feb;70(2):519–527. [PubMed]
- Papadakis, MA; Grady, D; Black, D; Tierney, MJ; Gooding, GA; Schambelan, M; Grunfeld, C. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med. 1996 Apr 15;124(8):708–716. [PubMed]
- Bowers, CY. On a peptidomimetic growth hormone-releasing peptide. J Clin Endocrinol Metab. 1994 Oct;79(4):940–942. [PubMed]
- Saenger, P. Oral growth hormone secretagogues--better than Alice in Wonderland's growth elixir? J Clin Endocrinol Metab. 1996 Aug;81(8):2773–2775. [PubMed]
- Chapman, IM; Bach, MA; Van Cauter, E; Farmer, M; Krupa, D; Taylor, AM; Schilling, LM; Cole, KY; Skiles, EH; Pezzoli, SS; Hartman, ML; Veldhuis, JD; Gormley, GJ; Thorner, MO. Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects. J Clin Endocrinol Metab. 1996 Dec;81(12):4249–4257. [PubMed]
|
This article has been 
